Exome Sequencing Improves Diagnosis of Fetal Structural Anomalies

Prenatal diagnostics have evolved from conventional cytogenetic analysis to increasingly chromosomal microarray analysis, within the last 10 years. While whole-exome sequencing (WES) has shown utility … [Read more...]


Evidence Suggests Need for Expanded HCV Testing, Particularly Coupled With Opioid Screening in Young People

Current hepatitis C virus (HCV) screening strategies may not be adequate in the face of the opioid epidemic. Previous screening guidelines have focused on reaching the estimated 2.7 million persons … [Read more...]


PAMA Unlocks Golden Age for Innovative Diagnostics

By Chance Scott  bio The publication of the 2018 Clinical Laboratory Fee Schedule (CLFS) in January saw a long and heated debate within the lab community come to fruition. When Congress … [Read more...]


Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry

For years it had been hoped that pharmacogenetic (PGx) testing would be a leading application for personalized medicine, but adoption of PGx testing has not lived up to its potential and remains in an … [Read more...]


New Study Provides Most Comprehensive Overview of Genetic Test Development, Usage and Spending

As might be expected, there has been rapid growth in genetic test availability and spending on these tests since 2014. But, comprehensive new collaborative analysis conducted by Concert Genetics … [Read more...]


Inside the Diagnostics Industry: Genotyping to Guide Antiplatelet Selection Feasible, Effective

Despite years of frustration that pharmacogenomic testing for antiplatelet therapy dosing has not been adopted as hoped in the field of cardiology, new evidence is emerging that genetic testing should … [Read more...]


Diagnostic danger in the lab: Time to reform how we process orders

By Oleg Bess, M.D.  bio I don't know about you, but I was stunned by the findings from a recent report published by Coverys, a national liability insurer, which I feel should put the entire … [Read more...]


Tests Emerging to Advance Cardiovascular Risk Assessment

While testing for cardiovascular conditions does not garner the headlines that oncology testing does, several recent studies demonstrate how the introduction of genetic testing and other new testing … [Read more...]


Outreach Survey Focuses on Clinical Laboratory Industry Trends Amidst Greatest Disruption in Three Decades

By Jeff Myers  bio Accumen Inc. is pleased to announce the launch of the 17th Annual National Hospital and Health System Laboratory and Outreach Survey. The survey is designed to capture … [Read more...]


FDA’s Two Big Moves on NGS-Based Tumor Panels May Offer Clues for Alternative Pathways for LDT Approval

In late November the U.S. Food and Drug Administration (FDA) authorized Memorial Sloan Kettering Cancer Center's Integrated Mutation Profiling of Actionable Cancer Targets tumor profiling test assay … [Read more...]